Literature DB >> 11096543

Sarcoidosis and the Heart.

.   

Abstract

The treatment of sarcoid cardiomyopathy can be considered in part the treatment of the systemic disorder, and in part cardiac involvement, the manifestations of which may differ greatly. Therapy for the systemic disease is corticosteroid. Therapy for cardiac involvement includes prednisone, but because treatment must ameliorate or abolish many differing manifestations, therapy differs among patients. Asymptomatic patients (the majority) who are free from serious manifestations of the disease do not require pharmacologic or interventional treatment. Patients with dilated cardiomyopathy require treatment for congestive heart failure. High-grade atrioventricular conduction delay usually necessitates a permanent electronic pacemaker. Life-threatening arrhythmia usually requires implantation of an automatic implantable cardiac defibrillator (AICD). Antiarrhythmic drugs may also be needed. Cardiac tamponade should be treated by drainage of pericardial fluid. Pericardiectomy is usually the appropriate treatment for patients who develop significant constrictive pericarditis. Calcium channel blockers may be helpful for severe diastolic dysfunction that occurs in those with restrictive cardiomyopathy. Therapy should be given to those few patients who manifest hypertrophic cardiomyopathy to relieve left ventricular outflow obstruction. Cardiac transplantation for intractable heart failure or arrhythmia may be needed.

Entities:  

Year:  2000        PMID: 11096543     DOI: 10.1007/s11936-000-0034-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  21 in total

1.  Idiopathic Cardiomyopathy.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

2.  Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids.

Authors:  A A Oni; R E Hershberger; D J Norman; J Ray; H Hovaguimian; A M Cobanoglu; J D Hosenpud
Journal:  J Heart Lung Transplant       Date:  1992 Mar-Apr       Impact factor: 10.247

Review 3.  Restrictive cardiomyopathy.

Authors:  S S Kushwaha; J T Fallon; V Fuster
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

4.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

5.  Steroid responsive cardiomyopathy.

Authors:  C S Probert; I Pavord; J Roland
Journal:  Int J Cardiol       Date:  1990-08       Impact factor: 4.164

6.  Cardiac sarcoidosis: response to steroids and transplantation.

Authors:  H A Valantine; H D Tazelaar; J Macoviak; A V Mullin; S A Hunt; M B Fowler; M E Billingham; J S Schroeder
Journal:  J Heart Transplant       Date:  1987 Jul-Aug

Review 7.  Mechanism of action of beta-blocking agents in heart failure.

Authors:  M R Bristow
Journal:  Am J Cardiol       Date:  1997-12-04       Impact factor: 2.778

8.  Successful treatment of myocardial sarcoidosis with steroids.

Authors:  R L Shammas; A Movahed
Journal:  Sarcoidosis       Date:  1994-03

Review 9.  NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.

Authors: 
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

Review 10.  The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis.

Authors:  H L Paz; D J McCormick; S P Kutalek; A Patchefsky
Journal:  Chest       Date:  1994-11       Impact factor: 9.410

View more
  7 in total

1.  Thyrotoxicosis with heart block.

Authors:  V Vassiliou
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

2.  A Diagnostic and Therapeutic Approach to Arrhythmias in Cardiac Sarcoidosis.

Authors:  Brian A Houston; Carolyn Park; Monica Mukherjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

3.  Cardiac sarcoidosis responding to monotherapy with infliximab.

Authors:  Imad Uthman; Zahi Touma; Maurice Khoury
Journal:  Clin Rheumatol       Date:  2007-03-30       Impact factor: 2.980

Review 4.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

Review 5.  Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach.

Authors:  Brian A Houston; Monica Mukherjee
Journal:  Clin Med Insights Cardiol       Date:  2014-11-19

6.  Left ventricular aneurysm and ventricular tachycardia as initial presentation of cardiac sarcoidosis.

Authors:  Ashraf Jmeian; Mohammad Thawabi; Irvin Goldfarb; Fayez Shamoon
Journal:  N Am J Med Sci       Date:  2015-03

7.  Massive pericardial effusion causing cardiac tamponade accompanied by elevated CA-125 and thoracic lymphadenopathy in sarcoidosis: a case report.

Authors:  Taalaibek Kudaiberdiev; Elmira Tukusheva; Zhanybek Gaibyldaev; Gulnaz Tursunbekova; Zhunus Kadyraliev; Irina Akhmedova; Nurjan Tulopbergenov; Emil Muraliev
Journal:  Int J Surg Case Rep       Date:  2020-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.